Suzanne Jones, PharmD – Sarah Cannon
Jeffrey C. Rathmell, PhD – Vanderbilt University School of Medicine
Anil Shanker, PhD – Meharry Medical College School of Medicine
ACI-Webcast Program Registration
Advanced online registration is NOW AVAILABLE.
Specifically designed by the Society for Immunotherapy of Cancer (SITC) for clinical oncologists, registered nurses, nurse practitioners, pharmacists, emergency physicians and the entire cancer care team, the Advances in Cancer Immunotherapy™ (ACI) programs are introductory, CME-, CPE-, CNE-, and MOC-certified programs. This program is presented by leading and local authorities in tumor immunology and cancer immunotherapy.
For more information on the program, click below.
The 2019-2020 ACI series is jointly provided by the Society for Immunotherapy of Cancer and Postgraduate Institute for Medicine.
The 2019-2020 Advances in Cancer Immunotherapy™ series is brought to you in collaboration with the American Academy of Emergency Medicine, the Association of Community Cancer Centers and the Hematology/Oncology Pharmacy Association.
The 2019–2020 Advances in Cancer Immunotherapy™ educational series is supported, in part, by independent medical education grants from Amgen, Bristol-Myers Squibb, Celgene Corporation, Exelixis, Inc., Genentech, Incyte Corporation and Merck & Co., Inc.